Evidence map›Paper›PMID 33905631›Full record

ReviewArchives of endocrinology and metabolism2021

Management of hypopituitarism: a perspective from the Brazilian Society of Endocrinology and Metabolism.

Heraldo Mendes Garmes, César Luiz Boguszewski, Paulo Augusto Carvalho Miranda, Manoel Ricardo Alves Martins, Silvia Regina Correa da Silva, Julio Zaki Abucham, Nina Rosa de Castro Musolino, Lucio Vilar, Luiz Henrique Corrêa Portari, Mônica Roberto Gadelha and 7 more

Open access · diamondAbstract readReview
In one paragraph

Review in Archives of endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Progress, challenges and perspectives in the management of hypopituitarism.Reviews in endocrine & metabolic disorders · 2024
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 2 countries.

Heraldo Mendes GarmesUnidade de Neuroendocrinologia, Divisão de Endocrinologia e Metabologia, Departamento de Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil, heraldmg@uol.com.br.
César Luiz BoguszewskiServiço de Endocrinologia e Metabologia, Departamento de Clínica Médica, Universidade Federal do Paraná (SEMPR), Curitiba, PR, Brasil, clbogus@uol.com.br.
Paulo Augusto Carvalho MirandaServiço de Endocrinologia e Metabologia, Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brasil.
Manoel Ricardo Alves MartinsDepartamento de Medicina Clínica, Faculdade de Medicina da Universidade Federal do Ceará, Fortaleza, CE, Brasil.
Silvia Regina Correa da SilvaUnidade de Neuroendocrinologia, Divisão de Endocrinologia e Metabolismo, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM-Unifesp), São Paulo, SP, Brasil.
Julio Zaki AbuchamUnidade de Neuroendocrinologia, Divisão de Endocrinologia e Metabolismo, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM-Unifesp), São Paulo, SP, Brasil.
Nina Rosa de Castro MusolinoUnidade de Neuroendocrinologia, Divisão de Neurocirurgia Funcional, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, DP, Brasil.
Lucio VilarServiço de Endocrinologia, Hospital das Clínicas da Universidade Federal de Pernambuco, Recife, PE, Brasil.
Luiz Henrique Corrêa PortariUnidade de Neuroendocrinologia, Divisão de Endocrinologia e Metabolismo, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM-Unifesp), São Paulo, SP, Brasil.
Mônica Roberto GadelhaUnidade de Neuroendocrinologia, Instituto Estadual do Cérebro Paulo Niemeyer, Centro de Pesquisa de Neuroendocrinologia, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Leandro KasukiUnidade de Neuroendocrinologia, Instituto Estadual do Cérebro Paulo Niemeyer, Centro de Pesquisa de Neuroendocrinologia, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Luciana Ansaneli NavesServiço de Endocrinologia, Faculdade de Medicina da Universidade de Brasília, Brasília, DF, Brasil.
Mauro Antônio CzepielewskiServiço de Endocrinologia, Hospital de Clínicas de Porto Alegre; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.
Tobias Skrebsky de AlmeidaServiço de Endocrinologia, Hospital de Clínicas de Porto Alegre; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.
Felipe Henning Gaia DuarteServiço de Endocrinologia Oncológica, A.C. Camargo Cancer Center, São Paulo, SP, Brasil.
Andrea GlezerUnidade de Neuroendocrinologia, Laboratório de Endocrinologia Celular e Molecular LIM-25, Divisão de Endocrinologia e Metabolismo, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brasil.
Marcello Delano BronsteinUnidade de Neuroendocrinologia, Laboratório de Endocrinologia Celular e Molecular LIM-25, Divisão de Endocrinologia e Metabolismo, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brasil.
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRUniversidade Federal de São Paulo · BRUniversidade Federal do Rio de Janeiro · BRUniversidade Federal do Rio Grande do Sul · BRAC Camargo Hospital · BRGrupo Santa Casa de Belo Horizonte · BRHospital das Clínicas da Universidade Federal de Pernambuco · BRHospital de Clínicas Universidade Federal do Paraná · BRUniversidade de Brasília · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypopituitarism is a disorder characterized by insufficient secretion of one or more pituitary hormones. New etiologies of hypopituitarism have been recently described, including head trauma, cerebral hemorrhage, and drug-induced hypophysitis. The investigation of patients with these new disorders, in addition to advances in diagnosis and treatment of hypopituitarism, has increased the prevalence of this condition. Pituitary hormone deficiencies can induce significant clinical changes with consequent increased morbidity and mortality rates, while hormone replacement based on current guidelines protects these patients. In this review, we will first discuss the different etiologies of hypopituitarism and then address one by one the clinical aspects, diagnostic evaluation, and therapeutic options for deficiencies of TSH, ACTH, gonadotropin, and GH. Finally, we will detail the hormonal interactions that occur during replacement of pituitary hormones.

Indexed as

EndocrinologyHypopituitarismBrazilHormone Replacement TherapyHumansPituitary HormonesPituitary Hormonescentral hypogonadism and GH deficiencycentral hypothyroidismHypopituitarismsecondary adrenal insufficiency

Identifiers

PMID33905631
PMCPMC10065316
OpenAlexW3135444546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.